on StartEngine
Health & WellnessTech
People of Color


Utilizing Gene Repair to Treat Diseases
Century City, 
Investment type:
(Common Stock)
Target raise:
 - $5,000,000
Minimum investment:​
End date:
Oct 27, 2021
Share on facebook
Share on twitter
Share on linkedin
Share on email
PhorMed is a biopharmaceutical company leading the charge in the field of genomic medicine. We are working to utilize gene therapy to treat diseases, allowing the body to begin healing itself, and give new hope to patients suffering from diseases like AML, Hodgkin’s Lymphoma, Parkinson’s disease, and viruses.